Diamond Therapeutics
Company

Diamond Therapeutics

Pharmaceutical Manufacturing Toronto, Ontario, Ca 8 employees
Employees
8
Contacts
2
Emails
2
Phones
1

Diamond Therapeutics Overview

Headquarters
Toronto, Ontario, Ca
Industry
Pharmaceutical Manufacturing
Employees
8
Founded
2018
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About Diamond Therapeutics

The promise of a new and better class of mental health therapies lies within the chemistry of psychedelic compounds. Our mission is to unlock it. We're developing safe, FDA, EMA and Health Canada approved therapies for neuropsychiatric conditions, starting with sub-perceptual psilocybin-based medicines that have the potential to deliver greater impact than current first-line treatments. Our first clinical program is focused on accessible psilocybin-based drugs that deliver rapid therapeutic outcomes without perceptual side effects. By eliminating the side effects, this intervention can be administered to a broad cohort of patients.

Diamond Therapeutics Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage
Phone contacts
1
25.0% coverage

Diamond Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Judy Blumstock
View
William Hilson Biotech - Executive Officer - Vc Investor
Email Phone
Richard Boadway Chairman at Diamond Therapeutics and Past Chairman and President of Freeing the Human Spirit (a Charity). Mentor to the CEO of Romaeris Corporation
Email
David Brown, Ph.d., PMP Seasoned Pharmaceutical Leader - Pharmaceutical Consultant - Board Member
View

Employees by Management Level

Individual contributor 2 profiles
Executive 1 profile

Compare Similar Companies to Diamond Therapeutics